RxDoctor Payments Data

Salem Salem, MD

Interventional Cardiology · Beaumont, TXNPI 1760737308

Payments from drug & device makers

$107,573in general payments, 2019–2025

Across 227 payments — averaging $473.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$77K
  • Medtronic$23K
  • Boston Scientific$4K
  • Abbott$1K
  • Abiomed$465
  • Merck$166
  • plus $1K from 22 others

What the payments were for

  • Grants$96,00089%
  • Travel & lodging$5,4745%
  • Food & beverage$6,0746%
  • Education$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,573 in reported general payments places this provider in the 85th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Medicare billing

Part B allowed, 2024
$15,571
Medicare patients
170
Services billed
240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$67,287
EntrestoSacubitril/Valsartan51$43,274
Prasugrel Hcl20$1,223
Metoprolol Succinate28$626
ClopidogrelClopidogrel Bisulfate32$606
Chlorthalidone34$604
Rosuvastatin Calcium32$442
Diltiazem 24hr Er (Cd)Diltiazem Hcl13$402
Potassium Chloride17$357
Carvedilol47$333
Atorvastatin Calcium55$318
Furosemide53$250
SotalolSotalol Hcl22$228
Amiodarone Hcl13$226
Digoxin17$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$139$67,28786 claims
NovartisEntresto$162$43,27451 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 686 interventional cardiology providers in Texas.

Other interventional cardiology in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →